Eclipsys Clients Outperform Peers in Quality Measures

To support healthcare organizations in making the appropriate technology decisions to maximize federal stimulus dollar opportunity, Eclipsys Corporation®, (NASDAQ:ECLP), The Outcomes Company®, today announced the multiple superior outcomes its client organizations are achieving today. With a client base that leads the industry in adoption of computerized physician order entry (CPOE), outperforms peers in composite performance across all Centers for Medicare and Medicaid Services (CMS) Quality Measures and clinical information systems that dominate the Magnet Recognition Program® hospitals, Eclipsys offers an industry-differentiating ability to support healthcare providers in meeting the expected "meaningful use” objectives of the American Recovery and Reinvestment Act (ARRA). In addition, the company’s analytics technology provides a solid foundation to meet the expected more stringent and outcomes-focused ARRA requirements in 2013 and 2015.

A Client Base Ranked No. 1 in Meeting Composite CMS Quality Measures; Dominates Magnet Hospitals

In conducting a competitive analysis study of CMS Core Measures performance, data identified Eclipsys clients as ranking No. 1 in composite performance across all CMS Quality Measures. The study, which was based on publicly available data from HIMSS Analytics and the U.S. Department of Health and Human Services Hospital Compare site, also identified that Eclipsys clients ranked No. 1 in adherence to surgery CMS criteria, while statistically tying in adherence to heart failure, acute myocardial infarction (AMI) and pneumonia.

According to Jay Deady, Eclipsys executive vice president of Client Solutions, Eclipsys clients’ superior quality outcomes are a factor of the advanced clinical decision support and embedded complex algorithms built into the company’s CPOE solution, which leverage more than 30 years of experience to transcend fundamental computerized order entry. "Proactive, advanced clinical decision support is going to be a critical success factor in meeting ARRA ‘meaningful use’ requirements,” said Deady. "The fact that our client base today is comprised of higher-performing organizations is a clear demonstration of what sets apart Eclipsys in helping healthcare organizations improve patient health status and outcomes, the fundamental goal behind this government act. With hundreds of healthcare organizations seeking a new clinical information system platform, we expect our proven track record and strong positioning to support us in achieving expanded market share.”

Industry CPOE Adoption Leadership

A key provision of ARRA is that healthcare organizations must drive the use of information technology to improve patient health status — not just demonstrate its existence or specific functionality. According to the KLAS CPOE Digest 2009: Meaningful Use and Physician Adoption report, deep adoption is pivotal to the overarching success of an electronic medical record (EMR) implementation. The same KLAS report concludes that Eclipsys leads the industry in total physicians live on CPOE and percentage of its client base using the system. Eclipsys also continues to have the highest physician satisfaction from clients who use its system, and on average, highly customizable ordering capabilities allow a physician to order faster than any other CPOE solution on the market.

In addition, Eclipsys’ clinical information systems dominate the field of Magnet Recognition Program® hospitals. Magnet status provides consumers with a benchmark to measure the quality of care they can expect to receive. Eclipsys clients represent 45 percent of all organizations receiving Magnet status, and represent 40 percent of the organizations listed as "America’s Best Hospitals,” according to the U.S. News & World Report’s 2009 ranking.

ARRA Requirement to Use Clinical Data in More Meaningful Ways

Along with the existing rise in pay-for-performance and changes in reimbursements, ARRA is expected to require healthcare organizations to use patient data to drive insight and intelligence about how systems and practice patterns are affecting care quality and outcomes. With the addition of the Sunrise Clinical Analytics™ business intelligence solution to what is slated to be Eclipsys’ ARRA 2011 Certified EHR (electronic health record) Technology, Eclipsys plans to offer hospitals unparalleled capabilities to meet increasingly complex quality reporting requirements. Sunrise Clinical Analytics intelligently extracts and transforms data at the right time from Eclipsys’ Sunrise Clinical Manager™ electronic health record solution to automate quality reporting. Ease of access to information is delivered without disruption to clinical workflows. The analytics system is designed to support organizations in effectively tracking and measuring clinical performance and identifying how clinician adoption impacts patient outcomes and clinical costs.

"We believe no other health information technology company can match our proven record of deep clinical adoption, our system agility to respond to changing environments and requirements and an unparalleled integrated clinical analytics solution,” added Deady. "Providers seeking to prepare for the implications of this momentous legislation should have confidence in selecting Eclipsys as their clinical technology partner.”

Eclipsys’ CPOE high adoption rates and speed are a factor of its embedded complex algorithms that leverage more than 30 years of experience to transcend fundamental order entry and offer a solution that is able to automatically interpret and recalculate new order protocols in real time based on any updates to the patient condition. The intuitive, easy-to-adopt solution offers highly complex clinical decision support capabilities that provide workflows tailored to how physician’s practice medicine and support fully automating even the most complex order sets and medication ordering, including the exacting protocols, long-range medication schedules and complicated treatment plans commonplace in oncology and pediatric care environments.

About the Magnet Recognition Program

The Magnet Recognition Program® was developed by the American Nurses Credentialing Center (ANNC) to recognize healthcare organizations that provide nursing excellence. The program also provides a vehicle for disseminating successful nursing practices and strategies. Recognizing quality patient care, nursing excellence and innovations in professional nursing practice, the Magnet Recognition Program provides consumers with the ultimate benchmark to measure the quality of care that they can expect to receive. For more information, go to www.nursingcredentialing.com.

About the Eclipsys Competitive Analysis Study and Hospital Compare Web site

Organizations for each vendor were identified from an HIMSS Analytics query. Hospitals with less than 100 beds were excluded from the analysis since recent reports suggest that organizations with a small bed base can score well mainly based on the lower volume of cases. The Hospital Compare Web site was used to cross-reference hospital CMS criteria performance. The Hospital Compare Web site was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Health and Human Services, and other members of the Hospital Quality Alliance: Improving Care Through Information (HQA). The information on this website comes from hospitals that have agreed to submit quality information for Hospital Compare to make public. For more information, go to www.hospitalcompare.hhs.gov.

About the KLAS CPOE Digest 2009

The KLAS CPOE Digest 2009 compiled data from healthcare executives, managers and clinicians. The study provided detailed information on several criteria including current CPOE usage at healthcare organizations, product capabilities and vendor performance.

About KLAS

KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial and operational outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Statements in this news release concerning the timing of implementation and features of and benefits provided by Eclipsys software and implementation services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software or services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors” and "Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Clinical Analytics and Sunrise Clinical Manager are trademarks of Eclipsys Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.